A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma

被引：0
|
作者：
Koenig, Julie L.
Pappas, Leon
Yeap, Beow Y.
Clark, Jeffrey William
Weekes, Colin D.
Allen, Jill N.
Blaszkowsky, Lawrence Scott
Ryan, David P.
Cleary, James M.
Mancias, Joseph Douglas
Schlechter, Benjamin L.
Slater, Sarah Elizabeth
Wo, Jennifer Yon-Li
Roberts, Hannah Johnson
Von Fedak, Sofia
Carzo, Nicole
Drapek, Lorraine C.
Mehta, Arnav
Hong, Theodore S.
Parikh, Aparna Raj
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol & Oncol, Dept Med, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA
[6] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4143
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab
    Ornstein, Moshe C.
    George, Laeth
    Wei, Wei
    Diaz-Montero, C. Marcela
    Rayman, Pat
    Martin, Allison
    Basu, Arnab
    Beckermann, Kathryn E.
    Nizam, Amanda
    Wee, Christopher E.
    Gilligan, Timothy D.
    Gupta, Shilpa
    Rini, Brian I.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [32] Exploratory biomarker analyses in phase 1 study of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
    Ye, Jian
    Wang, Chongkai
    Egelston, Colt
    Guo, Weihua
    Lee, Peter P.
    Fakih, Marwan
    CANCER RESEARCH, 2023, 83 (07)
  • [33] A multi-center phase II study of nivolumab plus /- ipilimumab for patients with metastatic sarcoma (Alliance A091401)
    D'Angelo, Sandra P.
    Mahoney, Michelle R.
    Van Tine, Brian Andrew
    Atkins, James N.
    Milhem, Mohammed M.
    Tap, William D.
    Antonescu, Cristina R.
    Horvath, Laura E.
    Schwartz, Gary K.
    Streicher, Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] A phase II study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer
    Ueno, Makoto
    Morizane, Chigusa
    Ikeda, Masafumi
    Sudo, Kentaro
    Hirashima, Yoshinori
    Kuroda, Masataka
    Fukuyama, Yuki
    Okusaka, Takuji
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [35] Neurologic Complications Effects of ipilimumab and nivolumab therapy in patients with metastatic melanoma
    Latchman, Jessica
    Guastella, Ann
    Tofthagen, Cindy
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2019, 23 (04) : 355 - 358
  • [36] Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma
    Cohen, SJ
    Ho, L
    Ranganathan, S
    Abbruzzese, JL
    Alpaugh, RK
    Beard, M
    Lewis, NL
    McLaughlin, S
    Rogatko, A
    Perez-Ruixo, JJ
    Thistle, AM
    Verhaeghe, T
    Wang, H
    Weiner, LM
    Wright, JJ
    Hudes, GR
    Meropol, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1301 - 1306
  • [37] Comparing radiation therapy and ipilimumab to ipilimumab alone in metastatic melanoma patients
    Patel, Kirtesh R.
    Oliver, Daniel E.
    Okwan-Dadu, Derick
    Liu, Yuan
    Kudchadkar, Ragini R.
    Lawson, David H.
    Khan, Mohammad K.
    CANCER RESEARCH, 2015, 75
  • [38] Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants
    Terrero, Gretel
    Datta, Jashodeep
    Dennison, Jessica
    Sussman, Daniel A.
    Lohse, Ines
    Merchant, Nipun B.
    Hosein, Peter J.
    JAMA ONCOLOGY, 2022, 8 (06) : 938 - 940
  • [39] Prospective Phase I/II Study of Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable NSCLC
    Liveringhouse, C.
    Lam, N. B.
    Rosenberg, S. A.
    Dilling, T. J.
    Macmillan, G.
    Chiappori, A.
    Haura, E. B.
    Creelan, B.
    Gray, J.
    Tanvetyanon, T.
    Shafique, M.
    Saltos, A. N.
    Weiner, A. A.
    Kelsey, C. R.
    Schell, M.
    Antonia, S. J.
    Perez, B. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S3 - S4
  • [40] PHASE II STUDY OF IPILIMUMAB PLUS TEMOZOLOMIDE IN PATIENTS WITH METASTATIC MELANOMA
    Patel, S.
    Bassett, R.
    Hwu, W.
    Kim, K.
    Papadopoulos, N.
    Hwu, P.
    Bedikian, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 366 - 367
12345